Cenatex Holdings LLC Increases Holdings of Bri-Chem Corp.

Rhea-AI Summary

Cenatex Holdings LLC has increased its stake in Bri-Chem Corp. (BRYFF) through two transactions. The company purchased 500 common shares at an average price of $0.1994 USD per share, totaling $99.70 USD. Additionally, Joint Actors Barry Hugghins and related IRA accounts transferred 1,120,820 common shares to Cenatex. Following these transactions, Cenatex now owns 3,701,040 common shares, representing 14.0016% of Bri-Chem's total outstanding shares of 26,432,981.

The transfer of shares from Joint Actors was done to streamline management of holdings. Cenatex indicates it may further adjust its position in Bri-Chem based on various factors including market conditions, price, availability of shares, and company developments.

Positive

• Consolidated ownership structure for more efficient management of holdings
• Increased stake shows confidence in the company from major shareholder

Negative

• Small purchase size ($99.70) suggests limited immediate investment interest
• Cenatex indicates potential future share sales, creating uncertainty

Garland, Texas--(Newsfile Corp. - May 12, 2025) - Cenatex Holdings, LLC ("Cenatex"), a Texas limited liability company, purchased an aggregate of 500 common shares (the "Common Shares") in the capital of Bri-Chem Corp. ("Bri-Chem") listed on the Toronto Stock Exchange at an average price of $0.1994 USD per Common Share, for an aggregate cost of $99.70 USD (the "Purchase"). In addition to this purchase, on May 5, Joint Actors Barry Hugghins, Barry Hugghins Individual Retirement Account, and Patricia Hugghins Individual Retirement Account transferred ownership of a total of 1,120,820 of their common shares to Cenatex.

Immediately prior to the Purchase, Cenatex owned, or had control or direction over, an aggregate of 3,700,540 Common Shares, representing 13.999% of the 26,432,981 shares issued and outstanding Common Shares. Following the Purchase, Cenatex owned and had control and direction of 3,701,040 Common Shares, representing 14.0016% of the 26,432,981 issued and outstanding Common Shares.

The Joint Actors transferred their Common Shares to Cenatex so that the holdings could be more easily managed. Cenatex purchased the additional Common Shares as a result of an investment decision, and based on current market conditions, Cenatex may, in the future, further increase or decrease its shareholdings in Bri-Chem, as circumstances warrant, whether in the open market, by privately negotiated agreements, or otherwise. Any transaction that Cenatex may pursue may be made at any time, and from time to time, without prior notice, and will depend on a variety of factors, including, and without limitation, the price and availability of common shares of Bri-Chem, subsequent developments affecting Bri-Chem, its business and prospects, other investments and business opportunities available to Cenatex, general industry and economic conditions, the securities markets in general, compliance with applicable securities laws, and other factors deemed relevant by Cenatex and joint actors.

An early warning report related to this transaction will be filed on SEDAR+ under Bri-Chem's profile at www.sedarplus.ca. To obtain a copy of such report, please contact

Cecil J. Cavanaugh, CPA, at 225-715-6351 or Barry Hugghins at 225-802-2664. The main office of Cenatex is located at 7405 Ramblewood Drive, Garland, Texas 75044. The main office of Bri-Chem is located at 27075 Acheson Road, Acheson, Alberta, T7X 6B1.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/251819

FAQ

What is Cenatex Holdings LLC's current ownership percentage in Bri-Chem Corp (BRYFF)?

After recent transactions, Cenatex Holdings LLC owns 14.0016% of Bri-Chem Corp, holding 3,701,040 common shares out of 26,432,981 total outstanding shares.

How many shares did Cenatex Holdings purchase of BRYFF in their latest transaction?

Cenatex Holdings purchased 500 common shares at an average price of $0.1994 USD per share, for a total cost of $99.70 USD.

Why did the Joint Actors transfer their Bri-Chem (BRYFF) shares to Cenatex Holdings?

The Joint Actors transferred their shares to Cenatex Holdings to facilitate easier management of the holdings.

What are Cenatex Holdings' future plans regarding their BRYFF shareholding?

Cenatex indicated they may increase or decrease their shareholdings in Bri-Chem based on factors including price, market conditions, company developments, and other investment opportunities.